Obesity pill

Search documents
‘Fed always wrong': Analyst slams Jerome Powell ahead of rate decision
Youtube· 2025-09-17 18:00
Group 1: Federal Reserve Interest Rate Cuts - The Federal Reserve is expected to cut interest rates for the first time this year, with predictions of up to three cuts by year-end [2][4][11] - Trump's influence through his Fed pick, Steven Myron, may push for more aggressive rate cuts [2][16][21] - Inflation is a key concern, with some arguing that rising inflation may warrant no cuts at all [2][12][14] Group 2: Market Reactions and Economic Indicators - The price of gold has reached an all-time high, indicating market concerns despite a general decrease in inflation [3][5] - Economic data, such as rising unemployment and job numbers, are influencing market sentiment and investment strategies [6][30] - The market is currently experiencing volatility, with significant movements in indices like the RSP equal weight index and NASDAQ [26][22] Group 3: Investment Strategies and Sector Focus - There is a shift towards smaller tech companies as larger tech stocks have seen significant sell-offs [8][28] - The environment is seen as favorable for small-cap names, particularly in the tech sector, due to anticipated lower interest rates [9][27] - The focus on growth prospects is strong, with expectations that the economic environment will improve, potentially leading to more investment opportunities [30][32]
X @Bloomberg
Bloomberg· 2025-09-16 22:16
Lilly’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said https://t.co/8uS45REPwH ...
X @Bloomberg
Bloomberg· 2025-08-26 10:50
Eli Lilly’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval https://t.co/Iaujssmvki ...
X @Bloomberg
Bloomberg· 2025-08-19 12:20
Viking Therapeutics plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative to popular weight-loss injections https://t.co/7dQrwfjyjo ...